KPHARMA LIMITED

Company Registration Number:
07571771 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2024

Period of accounts

Start date: 01 April 2023

End date: 31 March 2024

KPHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Notes

KPHARMA LIMITED

Balance sheet

As at 31 March 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 612 765
Total fixed assets: 612 765
Current assets
Debtors:   13,452 16,367
Cash at bank and in hand: 154,689 105,661
Total current assets: 168,141 122,028
Creditors: amounts falling due within one year:   (90,374) (71,788)
Net current assets (liabilities): 77,767 50,240
Total assets less current liabilities: 78,379 51,005
Total net assets (liabilities): 78,379 51,005
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 78,279 50,905
Shareholders funds: 78,379 51,005

The notes form part of these financial statements

KPHARMA LIMITED

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 26 September 2024
and signed on behalf of the board by:

Name: Mr K Chotai
Status: Director

The notes form part of these financial statements

KPHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

KPHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

2. Employees

2024 2023
Average number of employees during the period 1 1

KPHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Tangible Assets

Total
Cost £
At 01 April 2023 4,515
At 31 March 2024 4,515
Depreciation
At 01 April 2023 3,750
Charge for year 153
At 31 March 2024 3,903
Net book value
At 31 March 2024 612
At 31 March 2023 765